EXPD vs HROW · P/E 26, rev $10.60B vs rev $199.6M
Expeditors International of Washington, Inc. (EXPD) versus Harrow Health Inc (HROW) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported HROW revenue for 2024-12-31 was $199.6M. Net income was -$17.5M. Revenue was up 53.3% from 2023-12-31 to 2024-12-31. HROW currently screens at market cap $1.28B.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. HROW currently screens at market cap $1.28B.
Not investment advice. Open the EXPD and HROW stock pages for the full models.
Not investment advice.